Table 2

Meta-analyses of type-specific HPV DNA prevalence in invasive cervical cancer [15] and women with normal cytology [14,17]

    Invasive cervical cancer

    Normal

N tested

% pos

95% CI

N tested

% pos

95% CI


HPV16

14595

54.4

53.6–55.2

76385

2.6

2.5–2.8

HPV18

14387

15.9

15.3–16.5

76385

0.9

0.8–1.0

HPV33

13827

4.3

4.0–4.6

74141

0.5

0.4–0.5

HPV45

9843

3.7

3.3–4.1

65806

0.4

0.4–0.4

HPV31

11960

3.5

3.2–3.9

74076

0.6

0.6–0.7

HPV58

10157

3.3

2.9–3.6

72877

0.9

0.8–1.0

HPV52

9509

2.5

2.2–2.8

69030

0.9

0.8–1.0

HPV35

9507

1.7

1.5–2.0

74084

0.4

0.3–0.4

HPV59

6972

1.0

0.8–1.3

64901

0.3

0.2–0.3

HPV51

7339

0.7

0.5–0.9

67139

0.6

0.6–0.7

HPV56

7427

0.7

0.5–0.9

68121

0.5

0.5–0.6

HPV39

7078

0.6

0.5–0.9

64521

0.4

0.3–0.4

HPV68

6723

0.5

0.3–0.7

63210

0.3

0.2–0.3

HPV73

5837

0.5

0.3–0.7

44063

0.1

0.1–0.1

HPV66

6664

0.3

0.2–0.5

59774

0.4

0.3–0.4

HPV70

5159

0.2

0.1–0.4

35014

0.3

0.3–0.3

HPV82

5352

0.1

0.1–0.3

42536

0.1

0.0–0.1

HPV6

9911

0.5

0.4–0.7

58370

0.3

0.2–0.3

HPV53

not reported

44,058

0.4

0.4–0.4

HPV26

not reported

44,098

0.0

0.0–0.1

HPV85

not studied in ICC meta-analysis

9,622

0.1

0.1 – 0.1

HPV67

not studied in ICC meta-analysis

18,041

0.0

0.0 – 0.0

HPV34

not studied in ICC meta-analysis

42,588

0.0

0.0 – 0.1

HPV30

not studied in ICC meta-analysis

8,773

0.0

0.0 – 0.1

HPV97

not studied in ICC meta-analysis

not studied in normal cytology meta-analysis


Schiffman et al. Infectious Agents and Cancer 2009 4:8   doi:10.1186/1750-9378-4-8

Open Data